UnitedHealth Rises as 30% of Prior Approvals Head for Removal

Corporate Action
โดย GuruFocus·US·Read original
Summary · why it matters

UnitedHealth Group rose about 0.8% to $399.4 on Wednesday after announcing that, starting October 1, UnitedHealthcare will eliminate prior-authorization requirements for a broad range of conditions, including selected outpatient procedures, echocardiograms, therapies, and chiropractic care. This move brings the company closer to its commitment to scrap approvals for 30% of services that previously required them. The stakes are high: UnitedHealth's second-quarter results showed $112 billion in revenue but only $8 billion in operating earnings, a 7.1% operating margin. At $399.405, the stock trades 32.59% below its GF Value estimate of $592.48, but removing friction could also lead to heavier medical utilization, so the company must balance easier access with cost control.

Impact on stocks 1

Aging Population · 1 stocks
UnitedHealth Group Incorporated
UNH
± MixedRegulationrelevance

Removing prior-authorization requirements could improve customer satisfaction but may increase medical utilization, affecting costs.